Wayne Old is a Cardiology physician affiliated with Sentara Norfolk General Hospital. OpenAlex indexes 32 publications with 645 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
612 Kingsborough Sq
Suite 100
Chesapeake, VA 233205041
Telephone
757-547-9294Registry record last updated 3 May 2018.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BridgeBio Pharma, Inc.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Abbott LaboratoriesProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.1%Beta blocker17.1%Metoprolol Succinate47%Carvedilol46%Metoprolol Tartrate7%Part D≥87 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)11.5%Entresto100%Part D≥75 patients+ 15 more classes in this area
Metabolism & gastrointestinal
12.7%SGLT2 inhibitor9.9%Jardiance70%Farxiga30%Part D≥51 patientsProton pump inhibitor1%Omeprazole100%Part D≥13 patients+ 3 more classes in this area
Blood & clotting
9.9%Factor Xa inhibitor7.1%Eliquis87%Xarelto13%Part D<11 patientsVitamin K antagonist1.4%Warfarin Sodium100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial
Circulation Cardiovascular Quality and Outcomes
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Raymond Benza, MD
Sentara Norfolk General Hospital
John Herre, MD
Sentara Norfolk General Hospital
John Colonna, MD
Sentara Norfolk General Hospital
Philip Gentlesk, MD
Sentara Norfolk General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”